News
First marketing authorization for RoTecPSMA®
First marketing authorization for RoTecPSMA® We are thrilled to
ROTOP Pharmaka GmbH Announces Investments from GENUI & SHS Capital and New President, ROTOP USA.
Andrew Varghese, President USA ROTOP Pharmaka GmbH ROTOP
Radiopharmacy: Radiation made in Saxony
Saxon radiopharmacy network nukliD® strengthens international visibility Today, Thursday 16
Healthcare Specialists GENUI and SHS Capital jointly invest in ROTOP
Healthcare Specialists GENUI and SHS Capital jointly invest in
ROTOP auf Expansionskurs!
Auf über 15.000 qm werden zukünftig in Dresden-Rossendorf Forschungs-
Wir spenden an den Bundesverband Kinderhospiz e.V.
Die besinnliche Zeit des Jahres ist angebrochen, und wir